Clinical and virologic assesment of three therapeutic options: antiviral Ganciclovir 0.15% ophthalmic gel, povidone-iodine 0.4% and physiologic saline solution 0.9% used in patients with acute adenoviral conjuntivitis.
Phase of Trial: Phase II
Latest Information Update: 01 Jul 2015
At a glance
- Drugs Ganciclovir (Primary)
- Indications Infectious conjunctivitis
- Focus Therapeutic Use
- 01 Jul 2015 New trial record